Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrike Schick

Showing results (61-70 of 141) with videos related to

Pageof 15
Sort By:
Head & Neck|December 15, 2018
Prognostic value of textural indices extracted from pretherapeutic 18-F FDG-PET/CT in head and neck squamous cell carcinomaCatherine Guezennec, Philippe Robin, Fanny Orlhac, et al.
Frontiers in Medicine|February 28, 2019
Diagnostic Value of FDG PET-CT Quantitative Parameters and Deauville-Like 5 Point-Scale in Predicting Malignancy of Focal Thyroid IncidentalomaPhilippe Thuillier, David Bourhis, Nathalie Roudaut, et al.
Molecular Cancer Therapeutics|July 17, 2016
CHK1 Inhibition Radiosensitizes Head and Neck Cancers to Paclitaxel-Based ChemoradiotherapyHolly E Barker, Radhika Patel, Martin McLaughlin, et al.
Radiation Oncology (London, England)|August 15, 2018
Optimized radiotherapy to improve clinical outcomes for locally advanced lung cancerNicolas Jaksic, Enrique Chajon, Julien Bellec, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 12, 2015
Trametinib radiosensitises RAS- and BRAF-mutated melanoma by perturbing cell cycle and inducing senescenceUlrike Schick, Joan Kyula, Holly Barker, et al.
Plos One|March 29, 2019
Inter-observer and segmentation method variability of textural analysis in pre-therapeutic FDG PET/CT in head and neck cancerCatherine Guezennec, David Bourhis, Fanny Orlhac, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 22, 2025
Management of oropharyngeal squamous cell carcinoma: 2025 updateVincent Grégoire, Kévin Quintin, Florence Huguet, et al.
Clinical Nuclear Medicine|November 25, 2020
Clinical Assessment of 177Lu-DOTATATE Quantification by Comparison of SUV-Based Parameters Measured on Both Post-PRRT SPECT/CT and 68Ga-DOTATOC PET/CT in Patients With Neuroendocrine Tumors: A Feasibility StudyPhilippe Thuillier, Meriem Maajem, Ulrike Schick, et al.
Frontiers in Oncology|December 9, 2021
Post-Operative Radiotherapy in Prostate Cancer: Is It Time for a Belt and Braces Approach?Nicolas Giraud, Nicolas Benziane-Ouaritini, Ulrike Schick, et al.
Cancers|November 27, 2021
Development of a Radiomic-Based Model Predicting Lymph Node Involvement in Prostate Cancer PatientsVincent Bourbonne, Vincent Jaouen, Truong An Nguyen, et al.
Pageof 15

Showing results (61-70 of 141) with videos related to

Sort By:
Pageof 15
Head & Neck|December 15, 2018
Prognostic value of textural indices extracted from pretherapeutic 18-F FDG-PET/CT in head and neck squamous cell carcinomaCatherine Guezennec, Philippe Robin, Fanny Orlhac, et al.
Frontiers in Medicine|February 28, 2019
Diagnostic Value of FDG PET-CT Quantitative Parameters and Deauville-Like 5 Point-Scale in Predicting Malignancy of Focal Thyroid IncidentalomaPhilippe Thuillier, David Bourhis, Nathalie Roudaut, et al.
Molecular Cancer Therapeutics|July 17, 2016
CHK1 Inhibition Radiosensitizes Head and Neck Cancers to Paclitaxel-Based ChemoradiotherapyHolly E Barker, Radhika Patel, Martin McLaughlin, et al.
Radiation Oncology (London, England)|August 15, 2018
Optimized radiotherapy to improve clinical outcomes for locally advanced lung cancerNicolas Jaksic, Enrique Chajon, Julien Bellec, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 12, 2015
Trametinib radiosensitises RAS- and BRAF-mutated melanoma by perturbing cell cycle and inducing senescenceUlrike Schick, Joan Kyula, Holly Barker, et al.
Plos One|March 29, 2019
Inter-observer and segmentation method variability of textural analysis in pre-therapeutic FDG PET/CT in head and neck cancerCatherine Guezennec, David Bourhis, Fanny Orlhac, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 22, 2025
Management of oropharyngeal squamous cell carcinoma: 2025 updateVincent Grégoire, Kévin Quintin, Florence Huguet, et al.
Clinical Nuclear Medicine|November 25, 2020
Clinical Assessment of 177Lu-DOTATATE Quantification by Comparison of SUV-Based Parameters Measured on Both Post-PRRT SPECT/CT and 68Ga-DOTATOC PET/CT in Patients With Neuroendocrine Tumors: A Feasibility StudyPhilippe Thuillier, Meriem Maajem, Ulrike Schick, et al.
Frontiers in Oncology|December 9, 2021
Post-Operative Radiotherapy in Prostate Cancer: Is It Time for a Belt and Braces Approach?Nicolas Giraud, Nicolas Benziane-Ouaritini, Ulrike Schick, et al.
Cancers|November 27, 2021
Development of a Radiomic-Based Model Predicting Lymph Node Involvement in Prostate Cancer PatientsVincent Bourbonne, Vincent Jaouen, Truong An Nguyen, et al.
Pageof 15